In this interview blog, Stephanie Langouet, Cmed’s Sr Vice President of CRO Operations, shares some of the challenges of drug development and research for rare diseases in children. She hopes that by sharing and properly collaborating we can all contribute to a better future for those who suffer from a rare disease.
What is a rare disease and why should they be studied? A rare disease is any disorder that affects a small percentage of the population.
The 9th Annual SCOPE Summit for Clinical Ops Executives conference was fun filled and productive. Held in Orlando, FL last week, the conference focused on innovative solutions in all aspects of clinical trial planning, management and operations.
We enjoyed speaking with many people who stopped at our booth wanting to find out more about how we combine our extensive experience in Data & Analytics with our encapsia® clinical data suite to set up and conduct trials smarter and more efficiently.
Cmed will demonstrate the eSource and live data analytics capabilities of encapsia®, a next generation clinical data suite, at Summit for Clinical Operations Executives 2018 this month. Cmed’s encapsia® is a cloud-based suite of apps that helps biotech and pharma sponsors transform the way data is captured, monitored and reviewed in clinical trials. Our innovative technology, combined with our experienced people provide real, tangible benefits including an immediacy of being able to see and take actions on your data, and provide reductions in the cost of running a study.